R&D and Intellectual Property

Research & Development (R&D) at Jubilant Pharmova Limited is an ever-evolving centre of excellence, remaining committed to its belief in innovation and quality, which helps magnify the Company’s business aspirations. The focus of our R&D is to enhance innovation, scientific efficiency and effectiveness in compliance with Jubilant Pharmova Limited’s core values and support the execution of business strategies. Our R&D continues to lead to new, innovative processes and knowledge-driven products that increase the efficiencies of our production and allow us to capitalise on opportunities for growth in competitive markets.

Multi-Skilled Workforce

Our multi-skilled R&D teams, with specialisation across the pharmaceutical value chain, focus on research into novel drug delivery systems, radiopharmaceuticals, allergenic extracts, analytical research and biological support, including clinical studies. R&D supports the activities of our various businesses by developing breakthrough technologies in new products, process chemistry, analytical chemistry, process intensification and establishing these technologies at a commercial scale.

Bengaluru, Karnataka - Drug discovery

G. Noida, Uttar Pradesh - Drug discovery

France - Drug discovery

Robust Compliance, Process Driven Approach

Our R&D centres operate with a strong process‑driven approach, fostering a disciplined work culture and ensuring robust regulatory compliance through a rigorous internal audit framework.

The team remains aligned with evolving regulations and technological trends, proactively maintaining pharmacopeial standards while adopting best industry practices. With innovation at the core, our IP‑enabled R&D initiatives have strengthened design capabilities, identified new opportunities, and developed alternative research strategies that minimize disputes and safeguard intellectual property across key global markets. Over the years, these efforts have yielded a growing portfolio of patents filed in India, the US, Europe, Canada, Australia, China, and other regions under the Patent Cooperation Treaty, reinforcing our leadership position in the generic pharmaceutical business in regulated markets.

Supporting Our Businesses.

Radiopharma

Our Radiopharmaceuticals business has a focused R&D team with radiochemistry expertise, based in Montreal, Canada. We also have a support team in India and the USA. The R&D team works on nuclear medicine for the diagnosis, treatment and monitoring of various diseases, as well as cancer treatment using radiopharmaceutical agents. It serves hospital-based customers (nuclear medicine physicians and technologists) and radiopharmacies, globally, with high-quality and reliable speciality products. The business is backed by a dedicated R&D team, specialising in drug discovery, product development, analytical chemistry, radiochemistry, animal testing, manufacturing, strong regulatory and medical affairs and commercial operations, all utilising radiation safety protocols. The areas of specialisation include cardiac, lung, bone and thyroid diseases. This team supports existing products and leads the development of new products. The R&D team is continually engaged in the development of new products and strive to enhance product offerings across diagnostics and therapeutics, increasing the bandwidth of products and their applications. We also have a strong device team consisting of electrical engineers, mechanical engineers, system engineers and component engineers.